| Literature DB >> 36085212 |
Alireza Joorabloo1, Tianqing Liu2.
Abstract
Macrophages are essential immune cells and play a major role in the immune response as pro-inflammatory or anti-inflammatory agents depending on their plasticity and functions. Infiltration and activation of macrophages are usually involved in wound healing. Herein, we first described macrophage polarization and their critical functions in wound healing process. It is addressed how macrophages collaborate with other immune cells in the wound microenvironment. Targeting macrophages by manipulating or re-educating macrophages in inflammation using nanomedicines is a novel and feasible strategy for wound management. We discussed the design and physicochemical properties of nanomaterials and their functions for macrophages activation and anti-inflammatory signaling during wound therapy. The mechanism of action of the strategies and appropriate examples are also summarized to highlight the pros and cons of those approaches. Finally, the potential of nanomedicines to modulate macrophage polarization for skin regeneration is discussed.Entities:
Keywords: Drug delivery; Macrophages regulation; Nanomaterial-macrophage interaction; Nanomaterials; Wound healing
Mesh:
Year: 2022 PMID: 36085212 PMCID: PMC9463766 DOI: 10.1186/s12951-022-01616-1
Source DB: PubMed Journal: J Nanobiotechnology ISSN: 1477-3155 Impact factor: 9.429
Fig. 1A schematic diagram of wound healing phases and mechanisms driving macrophage phenotypes in wound microenvironment
Fig. 2The transition of M1 to M2 phenotype in normal wound healing and chronic wounds
Fig. 3Physicochemical properties of biomaterials and biomaterials-based delivery of bioactive agents to trigger macrophage polarization
Classification of nanoparticles-based materials for delivery of relevant payloads to modulate macrophage phenotypes in the wound healing process
| Type of nanoparticles | Payload | In vitro/in vivo model | Pathways | Therapeutic strategies | References |
|---|---|---|---|---|---|
| Drug-free inorganic nanomaterials induce macrophage polarization | |||||
| BGNPs | – | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| BGNPs | – | In vivo | Macrophage proliferation and polarization toward M2 phenotype to facilitate wound closure and re-epithelialization in diabetic wounds | Polarization of M1 to M2 phenotype | [ |
| Gold-mesoporous BGNPs | – | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| Ceria nanocrystals decorated MSNPs | – | In vivo | Reducing ROS, differentiation of monocytes to macrophages, and modulation of anti-inflammatory factors | Polarization of M1 to M2 phenotype | [ |
| Drug-free organic nanomaterials induce macrophage polarization | |||||
| Nanofibrous scaffolds including copolymer of poly(lactide-co-caprolactone) and heart decellularized ECM | – | In vivo | Collagen deposition and decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| Thioether grafted hyaluronic acid nanofibrous | – | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| Coaxial nanofibers of PLGA/fibrinogen and PLGA/collagen | – | In vivo | Promotion of the secretion of immunosuppressive factors as well as wound healing growth factors | Polarization of M1 to M2 phenotype | [ |
| α-Gal epitope nanoparticles | – | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| Supramolecular peptide hydrogel nanoparticles | – | In vitro | Reduction of NO and decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| Amphiphilic galactomannan nanoparticles | – | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| Drug-free organic–inorganic hybrid nanomaterials induce macrophage polarization | |||||
| Metallic AgNPs–collagen/chitosan scaffold | – | In vivo | Promotion of the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| Magnesium particles embedded in electrospun PCL nanofibers | – | In vivo | Collagen deposition and decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| SiO2 nanoparticles were modified by konjac glucomannan | – | In vivo | Collagen deposition and decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| AgNPs was decorated with zwitterionic poly(carboxybetaine-co-dopamine methacrylamide) copolymer | – | In vivo | Acceleration of the migration of fibroblast cells, factors for pro-inflammatory level increased as well as markers for macrophage activity | Polarization of M1 to M2 phenotype | [ |
| Inorganic/organic hybrid nanocomposites of silver/talc nanoparticles coated with chitosan | – | In vivo | Increasing vascularization and angiogenesis, collagen deposition and decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| Gold/perlite mesoporous nanocomposites coated with chitosan | – | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| Magnesium-containing BGNPs incorporated with hyaluronic acid and quaternized chitosan hydrogels | – | In vivo | Increasing vascularization and angiogenesis, collagen deposition and decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| Drug-loaded inorganic nanomaterials induce macrophage polarization | |||||
| AgNPs | Tannic acid | In vivo | Promotion of epithelialization, angiogenesis, and granulation tissue by increasing the expression of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| Super paramagnetic iron oxide nanoparticles | Heparin bonded fibroblast growth factor | In vivo | Controlled release of fibroblast growth factor. Granulation formation and collagen deposition due to the promotion of cell proliferation and M2 phenotype polarization | Polarization of M1 to M2 phenotype | [ |
| AuNPs | Snail mucus (Helix Aspersa) | In vitro | Reduction of LPS induced IL-6 and IL-1ꞵ cytokine levels and elimination of iNOS synthesis | Depletion of M1 phenotype | [ |
| Drug-loaded organic nanomaterials induce macrophage polarization | |||||
| Silk nanofiber | Asiaticoside | In vivo | Regulation of inflammatory reaction and vascularization | Polarization of M1 to M2 phenotype | [ |
| Hyaluronic acid nanoparticles | miR-223 | In vivo | Increasing anti-inflammatory gene and decreasing pro-inflammatory markers | Polarization of M1 to M2 phenotype | [ |
| Phenyl boronic acid-modified alginate nanocapsules | Amikacin and naproxen | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| Membrane with nanotopography of dihydroxyterephthaldehyde and 5,10,15,20-(tetra-4-aminophenyl)porphyrin | Ibuprofen | In vivo | Reducing the inflammatory reaction of macrophages and increasing the proportion of M2 macrophages at the injury site | Polarization of M1 to M2 phenotype | [ |
| Phosphatidylserine-nanoliposomes | Apoptotic cell | In vivo | Increasing the related cytokines to M2 macrophages, expression of the vascular endothelial marker CD31and accelerate wound closure | Polarization of M1 to M2 phenotype | [ |
| Drug-loaded organic–inorganic hybrid nanomaterials induce macrophage polarization | |||||
| MSNPs coated with collagen | Gentamicin and rifamycin | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |
| Mesoporous silica coated AgNPs in poloxamer hydrogel | Gentamicin | In vivo | decreasing the related cytokines to M1 macrophages, expression of the marker CD86 and accelerate diabetic wound healing | Depletion of M1 phenotype | [ |
| MSNPs coated with cellulose acetate | Econazole nitrate and triamcinolone acetonide | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [ |